Cell Line Development Market Size By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-Mammalian {Insects, Amphibians}), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Feb 2020  |  Report ID: GMI429  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 200   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1.    Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data Sources

1.4.1.    Secondary

1.4.1.1.    Paid Sources

1.4.1.2.    Unpaid Sources

1.4.2.    Primary

Chapter 2.    Executive Summary

2.1. Cell line development industry 360° synopsis, 2015 - 2026

2.1.1.    Business trends

2.1.2.    Product trends

2.1.3.    Source trends

2.1.4.    Cell line trends

2.1.5.    Application trends

2.1.6.    Regional trends

Chapter 3.    Cell Line Development Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.    Growth drivers

3.3.1.1.    Growing vaccine production worldwide

3.3.1.2.    Increasing cancer prevalence in developing countries

3.3.1.3.    Growth in biotechnology industry across the globe

3.3.1.4.    Innovations in biologics due to patent expiration

3.3.1.5.    Rising demand for monoclonal antibodies in developed economies

3.3.1.6.    Technological innovation in cell line development

3.3.2.    Industry pitfalls & challenges

3.3.2.1.    Complex regulatory landscape

3.3.2.2.    Issues related to stem cell research

3.4. Growth potential analysis

3.4.1.    By product

3.4.2.    By source

3.4.3.    By cell line type

3.4.4.    By application

3.5. Porter’s analysis

3.6. Competitive landscape

3.6.1.    Strategy dashboard, 2019

3.7. PESTEL analysis

Chapter 4.    Cell Line Development Market, By Product

4.1. Key segment trends

4.2. Reagents and media

4.2.1.    Reagents and media market, by region, 2015 - 2026 (USD Million)

4.3. Equipment

4.3.1.    Equipment market, by region, 2015 - 2026, (USD Million)

4.3.2.    Incubators

4.3.2.1.    Incubators market, by region, 2015 - 2026, (USD Million)

4.3.3.    Centrifuges

4.3.3.1.    Centrifuges market, by region, 2015 - 2026, (USD Million)

4.3.4.    Bioreactors

4.3.4.1.    Bioreactors market, by region, 2015 - 2026, (USD Million)

4.3.5.    Storage equipment

4.3.5.1.    Storage equipment market, by region, 2015 - 2026, (USD Million)

4.3.6.    Microscopes

4.3.6.1.    Microscopes market, by region, 2015 - 2026, (USD Million)

4.4. Accessories and consumables

4.4.1.    Accessories and consumables market, by region, 2015 - 2026, (USD Million)

Chapter 5.    Cell Line Development Market, By Source

5.1. Key segment trends

5.2. Mammalian

5.2.1.    Mammalian cell line development market, by region, 2015 - 2026, (USD Million)

5.3. Non-mammalian

5.3.1.    Non-mammalian cell development market, by region, 2015 - 2026, (USD Million)

5.3.2.    Insects

5.3.2.1.    Insect cell line development market, by region, 2015 - 2026, (USD Million)

5.3.3.    Amphibians

5.3.3.1.    Amphibians cell line development market, by region, 2015 - 2026, (USD Million)

Chapter 6.    Cell Line Development Market, By Cell Line

6.1. Key segment trends

6.2. Recombinant cell lines

6.2.1.    Recombinant cell lines market, by region, 2015 - 2026, (USD Million)

6.3. Hybridomas

6.3.1.    Hybridomas cell lines market, by region, 2015 - 2026, (USD Million)

6.4. Continuous cell lines

6.4.1.    Continuous cell lines market, by region, 2015 - 2026, (USD Million)

6.5. Primary cell lines

6.5.1.    Primary cell lines market, by region, 2015 - 2026, (USD Million)

Chapter 7.    Cell Line Development Market, By Application

7.1. Key segment trends

7.2. Bioproduction market

7.2.1.    Bioproduction market, by region, 2015 - 2026, (USD Million)

7.3. Drug discovery

7.3.1.    Drug discovery market, by region, 2015 - 2026, (USD Million)

7.4. Toxicity testing

7.4.1.    Toxicity testing market, by region, 2015 - 2026, (USD Million)

7.5. Tissue engineering

7.5.1.    Tissue engineering market, by region, 2015 - 2026, (USD Million)

7.6. Research

7.6.1.    Research market, by region, 2015 - 2026, (USD Million)

Chapter 8.    Cell Line Development Market, By Region

8.1. Key regional trends

8.2. North America

8.2.1.    North America cell line development market, by region, 2015 - 2026 (USD Million)

8.2.2.    North America cell line development market, by product, 2015 - 2026 (USD Million)

8.2.2.1.    North America cell line development market, by equipment, 2015 - 2026 (USD Million)

8.2.3.    North America cell line development market, by source, 2015 - 2026 (USD Million)

8.2.3.1.    North America cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.2.4.    North America cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.2.5.    North America cell line development market, by application, 2015 - 2026 (USD Million)

8.2.6.    U.S.

8.2.6.1.    U.S. cell line development market, by product, 2015 - 2026 (USD Million)

8.2.6.1.1. U.S. cell line development market, by equipment, 2015 - 2026 (USD Million)

8.2.6.2.    U.S. cell line development market, by source, 2015 - 2026 (USD Million)

8.2.6.2.1. U.S. cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.2.6.3.    U.S. cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.2.6.4.    U.S. cell line development market, by application, 2015 - 2026 (USD Million)

8.2.7.    Canada

8.2.7.1.    Canada cell line development market, by product, 2015 - 2026 (USD Million)

8.2.7.1.1. Canada cell line development market, by equipment, 2015 - 2026 (USD Million)

8.2.7.2.    Canada cell line development market, by source, 2015 - 2026 (USD Million)

8.2.7.2.1. Canada cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.2.7.3.    Canada cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.2.7.4.    Canada cell line development market, by application, 2015 - 2026 (USD Million)

8.3. Europe   

8.3.1.    Europe cell line development market, by country 2015 - 2026 (USD Million)

8.3.2.    Europe cell line development market, by product, 2015 - 2026 (USD Million)

8.3.2.1.    Europe cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.3.    Europe cell line development market, by source, 2015 - 2026 (USD Million)

8.3.3.1.    Europe cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.4.    Europe cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.5.    Europe cell line development market, by application, 2015 - 2026 (USD Million)

8.3.6.    Germany

8.3.6.1.    Germany cell line development market, by product, 2015 - 2026 (USD Million)

8.3.6.1.1. Germany cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.6.2.    Germany cell line development market, by source, 2015 - 2026 (USD Million)

8.3.6.2.1. Germany cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.6.3.    Germany cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.6.4.    Germany cell line development market, by application, 2015 - 2026 (USD Million)

8.3.7.    France

8.3.7.1.    France cell line development market, by product, 2015 - 2026 (USD Million)

8.3.7.1.1. France cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.7.2.    France cell line development market, by source, 2015 - 2026 (USD Million)

8.3.7.2.1. France cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.7.3.    France cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.7.4.    France cell line development market, by application, 2015 - 2026 (USD Million)

8.3.8.    UK

8.3.8.1.    UK cell line development market, by product, 2015 - 2026 (USD Million)

8.3.8.1.1. UK cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.8.2.    UK cell line development market, by source, 2015 - 2026 (USD Million)

8.3.8.2.1. UK cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.8.3.    UK cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.8.4.    UK cell line development market, by application, 2015 - 2026 (USD Million)

8.3.9.    Spain

8.3.9.1.    Spain cell line development market, by product, 2015 - 2026 (USD Million)

8.3.9.1.1. Spain cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.9.2.    Spain cell line development market, by source, 2015 - 2026 (USD Million)

8.3.9.2.1. Spain cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.9.3.    Spain cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.9.4.    Spain cell line development market, by application, 2015 - 2026 (USD Million)

8.3.10. Italy

8.3.10.1.    Italy cell line development market, by product, 2015 - 2026 (USD Million)

8.3.10.1.1.    Italy cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.10.2.    Italy cell line development market, by source, 2015 - 2026 (USD Million)

8.3.10.2.1.    Italy cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.10.3.    Italy cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.10.4.    Italy cell line development market, by application, 2015 - 2026 (USD Million)

8.3.11. Russia

8.3.11.1.    Russia cell line development market, by product, 2015 - 2026 (USD Million)

8.3.11.1.1.    Russia cell line development market, by equipment, 2015 - 2026 (USD Million)

8.3.11.2.    Russia cell line development market, by source, 2015 - 2026 (USD Million)

8.3.11.2.1.    Russia cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.3.11.3.    Russia cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.3.11.4.    Russia cell line development market, by application, 2015 - 2026 (USD Million)

8.4. Asia Pacific

8.4.1.    Asia Pacific cell line development market, by country, 2015 - 2026 (USD Million)

8.4.2.    Asia Pacific cell line development market, by product, 2015 - 2026 (USD Million)

8.4.2.1.    Asia Pacific cell line development market, by equipment, 2015 - 2026 (USD Million)

8.4.3.    Asia Pacific cell line development market, by source, 2015 - 2026 (USD Million)

8.4.3.1.    Asia Pacific cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.4.4.    Asia Pacific cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.4.5.    Asia Pacific cell line development market, by application, 2015 - 2026 (USD Million)

8.4.6.    Japan

8.4.6.1.    Japan cell line development market, by product, 2015 - 2026 (USD Million)

8.4.6.1.1. Japan cell line development market, by equipment, 2015 - 2026 (USD Million)

8.4.6.2.    Japan cell line development market, by source, 2015 - 2026 (USD Million)

8.4.6.2.1. Japan cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.4.6.3.    Japan cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.4.6.4.    Japan cell line development market, by application, 2015 - 2026 (USD Million)

8.4.7.    China

8.4.7.1.    China cell line development market, by product, 2015 - 2026 (USD Million)

8.4.7.1.1. China cell line development market, by equipment, 2015 - 2026 (USD Million)

8.4.7.2.    China cell line development market, by source, 2015 - 2026 (USD Million)

8.4.7.2.1. China cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.4.7.3.    China cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.4.7.4.    China cell line development market, by application, 2015 - 2026 (USD Million)

8.4.8.    India

8.4.8.1.    India cell line development market, by product, 2015 - 2026 (USD Million)

8.4.8.1.1. India cell line development market, by equipment, 2015 - 2026 (USD Million)

8.4.8.2.    India cell line development market, by source, 2015 - 2026 (USD Million)

8.4.8.2.1. India cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.4.8.3.    India cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.4.8.4.    India cell line development market, by application, 2015 - 2026 (USD Million)

8.4.9.    South Korea

8.4.9.1.    South Korea cell line development market, by product, 2015 - 2026 (USD Million)

8.4.9.1.1. South Korea cell line development market, by equipment, 2015 - 2026 (USD Million)

8.4.9.2.    South Korea cell line development market, by source, 2015 - 2026 (USD Million)

8.4.9.2.1. South Korea cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.4.9.3.    South Korea cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.4.9.4.    South Korea cell line development market, by application, 2015 - 2026 (USD Million)

8.4.10. Australia

8.4.10.1.    Australia cell line development market, by product, 2015 - 2026 (USD Million)

8.4.10.1.1.    Australia cell line development market, by equipment, 2015 - 2026 (USD Million)

8.4.10.2.    Australia cell line development market, by source, 2015 - 2026 (USD Million)

8.4.10.2.1.    Australia cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.4.10.3.    Australia cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.4.10.4.    Australia cell line development market, by application, 2015 - 2026 (USD Million)

8.5. Latin America

8.5.1.    Latin America cell line development market, by country 2015 - 2026 (USD Million)

8.5.2.    Latin America cell line development market, by product, 2015 - 2026 (USD Million)

8.5.2.1.    Latin America cell line development market, by equipment, 2015 - 2026 (USD Million)

8.5.3.    Latin America cell line development market, by source, 2015 - 2026 (USD Million)

8.5.3.1.    Latin America cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.5.4.    Latin America cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.5.5.    Latin America cell line development market, by application, 2015 - 2026 (USD Million)

8.5.6.    Mexico

8.5.6.1.    Mexico cell line development market, by product 2015 - 2026 (USD Million)

8.5.6.1.1. Mexico cell line development market, by equipment, 2015 - 2026 (USD Million)

8.5.6.2.    Mexico cell line development market, by source, 2015 - 2026 (USD Million)

8.5.6.2.1. Mexico cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.5.6.3.    Mexico cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.5.6.4.    Mexico cell line development market, by application, 2015 - 2026 (USD Million)

8.5.7.    Brazil

8.5.7.1.    Brazil cell line development market, by product 2015 - 2026 (USD Million)

8.5.7.1.1. Brazil cell line development market, by equipment, 2015 - 2026 (USD Million)

8.5.7.2.    Brazil cell line development market, by source, 2015 - 2026 (USD Million)

8.5.7.2.1. Brazil cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.5.7.3.    Brazil cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.5.7.4.    Brazil cell line development market, by application, 2015 - 2026 (USD Million)

8.6. MEA

8.6.1.    MEA cell line development market, by country 2015 - 2026 (USD Million)

8.6.2.    MEA cell line development market, by product, 2015 - 2026 (USD Million)

8.6.2.1.    MEA cell line development market, by equipment, 2015 - 2026 (USD Million)

8.6.3.    MEA cell line development market, by source, 2015 - 2026 (USD Million)

8.6.3.1.    MEA cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.6.4.    MEA cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.6.5.    MEA cell line development market, by application, 2015 - 2026 (USD Million)

8.6.6.    South Africa

8.6.6.1.    South Africa cell line development market, by product 2015 - 2026 (USD Million)

8.6.6.1.1.    South Africa cell line development market, by equipment, 2015 - 2026 (USD Million)

8.6.6.2.    South Africa cell line development market, by source, 2015 - 2026 (USD Million)

8.6.6.2.1.    South Africa cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.6.6.3.    South Africa cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.6.6.4.    South Africa cell line development market, by application, 2015 - 2026 (USD Million)

8.6.7.    Saudi Arabia

8.6.7.1.    Saudi Arabia cell line development market, by product 2015 - 2026 (USD Million)

8.6.7.1.1.    Saudi Arabia cell line development market, by equipment, 2015 - 2026 (USD Million)

8.6.7.2.    Saudi Arabia cell line development market, by source, 2015 - 2026 (USD Million)

8.6.7.2.1.    Saudi Arabia cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

8.6.7.3.    Saudi Arabia cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

8.6.7.4.    Saudi Arabia cell line development market, by application, 2015 - 2026 (USD Million)

Chapter 9.    Company Profiles

9.1. GE Healthcare

9.1.1.    Business Overview

9.1.2.    Financial Data

9.1.3.    Product Landscape

9.1.4.    Strategic Outlook

9.1.5.    SWOT Analysis

9.2. Thermo Fisher Scientific Inc.

9.2.1.    Business Overview

9.2.2.    Financial Data

9.2.3.    Product Landscape

9.2.4.    Strategic Outlook

9.2.5.    SWOT Analysis

9.3. Lonza Group AG

9.3.1.    Business Overview

9.3.2.    Financial Data

9.3.3.    Product Landscape

9.3.4.    Strategic Outlook

9.3.5.    SWOT Analysis

9.4. Sigma-Aldrich Corporation (Merck)

9.4.1.    Business Overview

9.4.2.    Financial Data

9.4.3.    Product Landscape

9.4.4.    Strategic Outlook

9.4.5.    SWOT Analysis

9.5. WuXi AppTec

9.5.1.    Business Overview

9.5.2.    Financial Data

9.5.3.    Product Landscape

9.5.4.    Strategic Outlook

9.5.5.    SWOT Analysis

9.6. American Type Culture Collection

9.6.1.    Business Overview

9.6.2.    Financial Data

9.6.3.    Product Landscape

9.6.4.    Strategic Outlook

9.6.5.    SWOT Analysis

9.7. Sartorius Stedim Biotech GmbH

9.7.1.    Business Overview

9.7.2.    Financial Data

9.7.3.    Product Landscape

9.7.4.    Strategic Outlook

9.7.5.    SWOT Analysis

9.8. Corning Inc.

9.8.1.    Business Overview

9.8.2.    Financial Data

9.8.3.    Product Landscape

9.8.4.    Strategic Outlook

9.8.5.    SWOT Analysis

9.9. Selexis SA

9.9.1.    Business Overview

9.9.2.    Financial Data

9.9.3.    Product Landscape

9.9.4.    Strategic Outlook

9.9.5.    SWOT Analysis

9.10.    Vista Biologicals Co.

9.10.1.    Business Overview

9.10.2.    Financial Data

9.10.3.    Product Landscape

9.10.4.    Strategic Outlook

9.10.5.    SWOT Analysis

9.11.    EuBiologics Co., Ltd.

9.11.1.    Business Overview

9.11.2.    Financial Data

9.11.3.    Product Landscape

9.11.4.    Strategic Outlook

9.11.5.    SWOT Analysis

9.12.    Paragon Bioservices

9.12.1.    Business Overview

9.12.2.    Financial Data

9.12.3.    Product Landscape

9.12.4.    Strategic Outlook

9.12.5.    SWOT Analysis

9.13.    Cobra Biologics

9.13.1.    Business Overview

9.13.2.    Financial Data

9.13.3.    Product Landscape

9.13.4.    Strategic Outlook

9.13.5.    SWOT Analysis

9.14.    Patheon

9.14.1.    Business Overview

9.14.2.    Financial Data

9.14.3.    Product Landscape

9.14.4.    Strategic Outlook

9.14.5.    SWOT Analysis

9.15.    Samsung Biologics

9.15.1.    Business Overview

9.15.2.    Financial Data

9.15.3.    Product Landscape

9.15.4.    Strategic Outlook

9.15.5.    SWOT Analysis

9.16.    NAEJA RGM Pharmaceuticals

9.16.1.    Business Overview

9.16.2.    Financial Data

9.16.3.    Product Landscape

9.16.4.    Strategic Outlook

9.16.5.    SWOT Analysis

9.17.    GVK BIO

9.17.1.    Business Overview

9.17.2.    Financial Data

9.17.3.    Product Landscape

9.17.4.    Strategic Outlook

9.17.5.    SWOT Analysis

9.18.    Progenitor Cell Therapy (PCT)

9.18.1.    Business Overview

9.18.2.    Financial Data

9.18.3.    Product Landscape

9.18.4.    Strategic Outlook

9.18.5.    SWOT Analysis

9.19.    Apath LLC

9.19.1.    Business Overview

9.19.2.    Financial Data

9.19.3.    Product Landscape

9.19.4.    Strategic Outlook

9.19.5.    SWOT Analysis

9.20.    Cell for Cure

9.20.1.    Business Overview

9.20.2.    Financial Data

9.20.3.    Product Landscape

9.20.4.    Strategic Outlook

9.20.5.    SWOT Analysis

9.21.    Epistem Holdings Plc

9.21.1.    Business Overview

9.21.2.    Financial Data

9.21.3.    Product Landscape

9.21.4.    Strategic Outlook

9.21.5.    SWOT Analysis

9.22.    Catalent Inc.

9.22.1.    Business Overview

9.22.2.    Financial Data

9.22.3.    Product Landscape

9.22.4.    Strategic Outlook

9.22.5.    SWOT Analysis

9.23.    Bioceros

9.23.1.    Business Overview

9.23.2.    Financial Data

9.23.3.    Product Landscape

9.23.4.    Strategic Outlook

9.23.5.    SWOT Analysis

9.24.    Abzena PLC

9.24.1.    Business Overview

9.24.2.    Financial Data

9.24.3.    Product Landscape

9.24.4.    Strategic Outlook

9.24.5.    SWOT Analysis

9.25.    Promocell

9.25.1.    Business Overview

9.25.2.    Financial Data

9.25.3.    Product Landscape

9.25.4.    Strategic Outlook

9.25.5.    SWOT Analysis

9.26.    Cyagen

9.26.1.    Business Overview

9.26.2.    Financial Data

9.26.3.    Product Landscape

9.26.4.    Strategic Outlook

9.26.5.    SWOT Analysis

   

Data Tables

TABLE 1.    Cell line development industry 360° synopsis, 2015 - 2026

TABLE 2.    Global cell line development market, 2015 - 2026 (USD Mn)

TABLE 3.    Global cell line development market, by product, 2015 – 2026 (USD Mn)

TABLE 4.    Global cell line development market, by source, 2015 – 2026 (USD Mn)

TABLE 5.    Global cell line development market, by type of cell lines, 2015 - 2026 (USD Mn)

TABLE 6.    Global cell line development market, by application, 2015 - 2026 (USD Mn)

TABLE 7.    Global cell line development market, by region, 2015 - 2026 (USD Million)

TABLE 8.    Industry impact forces

TABLE 9.    Reagents and media market by region, 2015 - 2026 (USD Million)

TABLE 10.    Equipment market, by region, 2015 - 2026, (USD Million)

TABLE 11.    Incubators market, by region, 2015 - 2026, (USD Million)

TABLE 12.    Centrifuges market, by region, 2015 - 2026, (USD Million)

TABLE 13.    Bioreactors market, by region, 2015 - 2026, (USD Million)

TABLE 14.    Storage equipment market, by region, 2015 - 2026, (USD Million)

TABLE 15.    Microscopes market, by region, 2015 - 2026, (USD Million)

TABLE 16.    Accessories and consumables market, by region, 2015 - 2026, (USD Million)

TABLE 17.    Mammalian cell line development market, by region, 2015 - 2026, (USD Million)

TABLE 18.    Non-mammalian cell development market, by region 2015 - 2026, (USD Million)

TABLE 19.    Insect cell line development market, by region 2015 - 2026, (USD Million)

TABLE 20.    Amphibians cell line development market, by region 2015 - 2026, (USD Million)

TABLE 21.    Recombinant cell line development market, by region, 2015 - 2026, (USD Million)

TABLE 22.    Hybridomas cell line development market, by region, 2015 - 2026, (USD Million)

TABLE 23.    Continuous cell line development market, by region, 2015 - 2026, (USD Million)

TABLE 24.    Primary cell line development market, by region, 2015 - 2026, (USD Million)

TABLE 25.    Bioproduction market, by region, 2015 - 2026, (USD Million)

TABLE 26.    Drug discovery market, by region, 2015 - 2026, (USD Million)

TABLE 27.    Toxicity testing market, by region, 2015 - 2026, (USD Million)

TABLE 28.    Tissue engineering market, by region, 2015 - 2026, (USD Million)

TABLE 29.    Research market, by region, 2015 - 2026, (USD Million)

TABLE 30.    North America cell line development market, by country 2015 - 2026 (USD Million)

TABLE 31.    North America cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 32.    North America cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 33.    North America cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 34.    North America cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 35.    North America cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 36.    North America cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 37.    U.S. cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 38.    U.S. cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 39.    U.S. cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 40.    U.S. cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 41.    U.S. cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 42.    U.S. cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 43.    Canada cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 44.    Canada cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 45.    Canada cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 46.    Canada cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 47.    Canada cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 48.    Canada cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 49.    Europe cell line development market, by country 2015 - 2026 (USD Million)

TABLE 50.    Europe cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 51.    Europe cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 52.    Europe cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 53.    Europe cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 54.    Europe cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 55.    Europe cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 56.    Germany cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 57.    Germany cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 58.    Germany cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 59.    Germany cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 60.    Germany cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 61.    Germany cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 62.    France cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 63.    France cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 64.    France cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 65.    France cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 66.    France cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 67.    France cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 68.    UK cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 69.    UK cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 70.    UK cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 71.    UK cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 72.    UK cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 73.    UK cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 74.    Spain cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 75.    Spain cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 76.    Spain cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 77.    Spain cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 78.    Spain cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 79.    Spain cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 80.    Italy cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 81.    Italy cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 82.    Italy cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 83.    Italy cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 84.    Italy cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 85.    Italy cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 86.    Russia cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 87.    Russia cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 88.    Russia cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 89.    Russia cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 90.    Russia cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 91.    Russia cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 92.    Asia Pacific cell line development market, by country, 2015 - 2026 (USD Million)

TABLE 93.    Asia Pacific cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 94.    Asia Pacific cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 95.    Asia Pacific cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 96.    Asia Pacific cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 97.    Asia Pacific cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 98.    Asia Pacific cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 99.    Japan cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 100.    Japan cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 101.    Japan cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 102.    Japan cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 103.    Japan cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 104.    Japan cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 105.    China cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 106.    China cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 107.    China cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 108.    China cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 109.    China cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 110.    China cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 111.    India cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 112.    India cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 113.    India cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 114.    India cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 115.    India cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 116.    India cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 117.    South Korea cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 118.    South Korea cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 119.    South Korea cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 120.    South Korea cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 121.    South Korea cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 122.    South Korea cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 123.    Australia cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 124.    Australia cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 125.    Australia cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 126.    Australia cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 127.    Australia cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 128.    Australia cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 129.    Latin America cell line development market, by country 2015 - 2026 (USD Million)

TABLE 130.    Latin America cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 131.    Latin America cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 132.    Latin America cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 133.    Latin America cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 134.    Latin America cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 135.    Latin America cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 136.    Mexico cell line development market, by product 2015 - 2026 (USD Million)

TABLE 137.    Mexico cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 138.    Mexico cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 139.    Mexico cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 140.    Mexico cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 141.    Mexico cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 142.    Brazil cell line development market, by product 2015 - 2026 (USD Million)

TABLE 143.    Brazil cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 144.    Brazil cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 145.    Brazil cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 146.    Brazil cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 147.    Brazil cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 148.    MEA cell line development market, by country 2015 - 2026 (USD Million)

TABLE 149.    MEA cell line development market, by product, 2015 - 2026 (USD Million)

TABLE 150.    MEA cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 151.    MEA cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 152.    MEA cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 153.    MEA cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 154.    MEA cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 155.    South Africa cell line development market, by product 2015 - 2026 (USD Million)

TABLE 156.    South Africa cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 157.    South Africa cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 158.    South Africa cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 159.    South Africa cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 160.    South Africa cell line development market, by application, 2015 - 2026 (USD Million)

TABLE 161.    Saudi Arabia cell line development market, by product 2015 - 2026 (USD Million)

TABLE 162.    Saudi Arabia cell line development market, by equipment, 2015 - 2026 (USD Million)

TABLE 163.    Saudi Arabia cell line development market, by source, 2015 - 2026 (USD Million)

TABLE 164.    Saudi Arabia cell line development market, by non-mammalian source 2015 - 2026 (USD Million)

TABLE 165.    Saudi Arabia cell line development market, by type of cell lines, 2015 - 2026 (USD Million)

TABLE 166.    Saudi Arabia cell line development market, by application, 2015 - 2026 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global cell line development market, 2015 - 2026 (USD Million)

FIG. 3    Cancer incidence in the U.S., 2005-2015

FIG. 4    Growth potential analysis, by product

FIG. 5    Growth potential analysis, by source

FIG. 6    Growth potential analysis, by cell line type

FIG. 7    Growth potential analysis, by application

FIG. 8    Porter’s analysis

FIG. 9    Strategy dashboard, 2019

FIG. 10    PESTEL analysis
 

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Feb 2020
  • Pages: 200
  • Tables: 166
  • Charts / Figures: 10
  • Companies covered: 26
  • Countries covered: 17

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X